<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Open Med Chem J</journal-id>
      <journal-id journal-id-type="publisher-id">TOMCJ</journal-id>
      <journal-title-group>
        <journal-title>The Open Medicinal Chemistry Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1874-1045</issn>
      <publisher>
        <publisher-name>Bentham Open</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3111732</article-id>
      <article-id pub-id-type="pmid">21673837</article-id>
      <article-id pub-id-type="publisher-id">TOMCJ-5-51</article-id>
      <article-id pub-id-type="doi">10.2174/1874104501105010051</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Thiadiazine Derivatives as Antiprotozoal New Drugs</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bermello</surname>
            <given-names>Julieta Coro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pi&#xF1;eiro</surname>
            <given-names>Rolando P&#xE9;rez</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fidalgo</surname>
            <given-names>Lianet Monzote</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cabrera</surname>
            <given-names>Hortensia Rodr&#xED;guez</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <xref ref-type="aff" rid="aff1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Navarro</surname>
            <given-names>Margarita Su&#xE1;rez</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">a</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Laboratorio de S&#xED;ntesis Org&#xE1;nica. Facultad de Quimica, Universidad de La Habana 10400-Ciudad Habana, Cuba;</aff>
      <aff id="aff2"><label>b</label>National Institute of Nanotechnology, National Research Council (NINT-NRC), and Department of Chemistry, University of Alberta, 11421 Saskatchewan Drive, Edmonton, AB T6G 2M9, Canada;</aff>
      <aff id="aff3"><label>c</label>Departamento de Parasitolog&#xED;a, Instituto de Medicina Tropical &#x201C;Pedro Kour&#xED;&#x201D;, Ciudad Habana, Cuba</aff>
      <author-notes>
        <corresp id="cor1"><label>*</label>Address correspondence to this autor at the Laboratorio de S&#xED;ntesis Org&#xE1;nica. Facultad de Quimica, Universidad de La Habana 10400-Ciudad Habana, Cuba; Tel 878-1398; E-mails: <email xlink:href="horten@fq.uh.cu">horten@fq.uh.cu</email>; <email xlink:href="hortensia_cu@yahoo.es">hortensia_cu@yahoo.es</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <volume>5</volume>
      <fpage>51</fpage>
      <lpage>60</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>2</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>29</day>
          <month>4</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Bermello <italic>et al</italic>.; Licensee <italic>Bentham Open</italic>.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Bermello</copyright-holder>
        <license license-type="open-access" xlink:href="http: //creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http: //creativecommons.org/licenses/by-nc/3.0/</uri>) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine-2-thione scaffold have found many applications in recent years. This review is aimed at highlighting the most important aspects about these compounds: synthesis, spectroscopic characterization and antiprotozoan activities. How the chemical nature of N-substituents influences the overall activity / cytotoxicity profile will also be discussed.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Tetrahydro-2H-1,3,5-thiadiazine-2-thione</kwd>
        <kwd>antiprotozoan activity.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <label>1</label>
      <title>INTRODUCTION</title>
      <p>Trypanosomatids are parasitic protozoa responsible for several tropical diseases of which African sleeping sickness (<italic>Trypanosoma brucei gambiense and T. b. rhodesiense</italic>), Chagas disease (<italic>T. cruzi</italic>), and the different forms of leishmaniasis (<italic>Leishmania dono</italic>V<italic>ani and L. infantum</italic>) are considered the most lethal [<xref ref-type="bibr" rid="R1">1</xref>]. At present, the chemotherapies associated with all forms of trypanosomiasis have many deficiencies, among them, poor efficacy, toxicity to humans, high cost, and the emergence of drug-resistant parasitic strains [<xref ref-type="bibr" rid="R2">2</xref>]. Unfortunately, because of the low profit margins associated with developing improved therapies for tropical diseases, there is no motivation for the pharmaceutical industry to develop better tropical disease drugs. Accordingly, many agencies, including the Special Program for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR), numerous academic research groups, various international/national bodies, and philanthropic foundations, have been sponsoring the discovery of new drug candidates for a number of tropical diseases [<xref ref-type="bibr" rid="R3">3</xref>].</p>
      <p>Recently, the tetrahydro-2<italic>H</italic>-1,3,5-thiadiazine-2-thione (THTT) derivatives have received special attention due to the pharmacological properties that they display like antiparasitic agents. Although the 3,5-disubstituted tetrahydro-2<italic>H</italic>-1,3,5-thiadiazine-2-thione (mono-THTT) scaffold (Fig. <bold><xref ref-type="fig" rid="F1">1</xref></bold>) was synthesized for the first time in 1848 [<xref ref-type="bibr" rid="R4">4</xref>], its accurate structure was established in 1944 [<xref ref-type="bibr" rid="R5">5</xref>]. The first publications of these compounds pointed out the significance of the nature of the substituent at N-3 on antimicrobial activity [<xref ref-type="bibr" rid="R6">6</xref>], and toxicity of the substituent on N-5 has been shown [<xref ref-type="bibr" rid="R7">7</xref>]. Optimum activities had been obtained in compounds bearing lipophilic groups at the N-3 and hydrophilic ones at 5<sup>th</sup> position [<xref ref-type="bibr" rid="R8">8</xref>].</p>
      <p>The principal studies on the THTT derivatives [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R26">26</xref>] take into account the molecular structure of these molecules to obtain the best activity/cytotoxicity relation. In this context, we found in the bibliography the reports on many compounds with one THTT ring as the central core with a great variety of substituents in N-3 and N-5 position (mono-THTT) [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R18">18</xref>]. In the last years, to enhance the antiprotozoal effect two THTT rings were incorporated into the same molecular structure, connected to each other via their N-3 atom by a linear or branch aliphatic backbone and bearing alkyl or carboxyalkyl residues at N-5 (bis-THTT)[<xref ref-type="bibr" rid="R19">19</xref>-<xref ref-type="bibr" rid="R26">26</xref>] (Fig. <bold><xref ref-type="fig" rid="F1">1</xref></bold>).</p>
      <p>Therefore this article will review the bibliography in order to show the development of new antiprotozoal agents using the THTT ring in their structure in the last ten years.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>CHEMISTRY CONSIDERATIONS</title>
      <sec>
        <label>2.1</label>
        <title> 3,5 disubstituted-tetrahydro-2<italic>H</italic>-1,3,5-thiadiazine-2-thione (Mono-THTT)</title>
        <p>The most used procedure to obtain the THTT derivatives is the reaction of the appropriate amine <bold>1</bold> with carbon disulfide <bold>2</bold> and potassium hydroxide <bold>3</bold>, to give the dithiocarbamate potassium salt <bold>4</bold> (which was not isolated), followed by cyclocondensation with formaldehyde <bold>5</bold> and the selected amino acids [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R13"> 13</xref>-<xref ref-type="bibr" rid="R15">15</xref>], pseudo peptides [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R13"> 13</xref>-<xref ref-type="bibr" rid="R18">18</xref>], and amines or amino ester (<bold>6</bold>) [<xref ref-type="bibr" rid="R12">12</xref>] able to provide the nitrogen at 5th position of the thiadiazine ring in fair to moderate or good yields. In the first step of these synthetic procedures, water is employed as a protic polar solvent in order to stabilize the dithiocarbamate intermediate <bold>4</bold>, in the second step pH 7-8 phosphate buffer was used (Scheme <bold><xref ref-type="fig" rid="S1">1</xref></bold>) [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R18">18</xref>].</p>
        <p>This methodology allowed the synthesis of 78 new mono-THTT derivatives to bunch up in at least seven series (Fig. <bold><xref ref-type="fig" rid="F2">2</xref></bold>). The series synthesized differ as to the nature (lipophilic or hydrophilic) of substituent at 3rd position. Some series bear an aromatic (furfuryl [<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R11">11</xref>], benzyl [<xref ref-type="bibr" rid="R11">11</xref>] and D or L deacylated chloramphenicol [<xref ref-type="bibr" rid="R12">12</xref>]) and alkyl or cycloalkyl (ethyl, butyl, octyl, dodecyl, cyclopropyl and cyclohexyl) [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R13"> 13</xref>-<xref ref-type="bibr" rid="R18">18</xref>] moiety, all of them lipophilic group; for other series the starting amines were hydrophilic (carboxyalkyl) group [<xref ref-type="bibr" rid="R9">9</xref>]. </p>
        <p>Another synthetic method used to obtain these compounds was the solid phase synthesis of 3-(5-carboxypentyl)-5-substituted tetrahydro-2<italic>H</italic>-1,3,5-thiadiazin-2-thione derivatives (<bold>Serie I</bold>). 6-Amino-<italic>n</italic>-hexanoic acid was attached via its C-terminal to hydroxymethyl polystyrene using a &#x2018;SASRIN&#x2019; linker. The bound amino acid was transformed into the corresponding dithiocarbamate <bold>8 </bold>followed by cyclization in the presence of formaldehyde and the corresponding free amino acids to afford 3-(5&#xB4;-carboxypentyl)-5-substituted tetrahydro-2<italic>H</italic>-1,3,5-thiadiazin-2-thiones (<bold>9</bold>). The final products <bold>I</bold> were cleaved from the resin and obtained in moderate yields due to low solubility of the corresponding free amino acids in 1,4 dioxan (Scheme <bold><xref ref-type="scheme" rid="S2">2</xref></bold>).</p>
        <p>Although its use is limited by two factors: the possibility for the starting amines to be properly functionalized for the efficient coupling to the resin and the low solubility of the amino acids in the solvent employed. The development of this methodology would allow the generation of combinatorial library for THTT compounds.</p>
      </sec>
      <sec>
        <label>2.2</label>
        <title>Alkyl-linked bis-(2-thioxo-[<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R5">5</xref>] thiadiazinan-3-yl) carboxylic acids (bis-THTT)</title>
        <p>The synthetic methods for obtaining bis-THTT have been much less reported in the bibliography than the synthetic route for mono-THTT [<xref ref-type="bibr" rid="R19">19</xref>-<xref ref-type="bibr" rid="R22">22</xref>]. The general procedure is very similar to the one used for mono-THTT. The bis-THTTs were always obtained using diamines <bold>10</bold> and the amounts of all reagents were duplicated. In the first step the diamine reacts with carbon disulfide <bold>2</bold> in the presence of potassium hydroxide <bold>3</bold> to obtain the expected bisdithiocarbamate salt <bold>11</bold>. The addition of formaldehyde <bold>5</bold> and the corresponding amine or aminoacid (<bold>6</bold>) to <bold>11</bold> resulted in the cyclocondensation in a slightly alkaline medium (phosphate buffer, pH 7-8) to generate, after treatment with HCl 15%, the desired bis-THTT (<bold>Scheme</bold> <bold><xref ref-type="fig" rid="S3">3</xref></bold>) [<xref ref-type="bibr" rid="R19">19</xref>-<xref ref-type="bibr" rid="R21">21</xref>].</p>
        <p>This procedure allowed the synthesis of 43 new bis-THTT derivatives to bunch up in at least four series (Fig. <bold><xref ref-type="fig" rid="F3">3</xref></bold>). All compounds were obtained in moderate to good yields except those of series <bold>IX</bold>, probably due to the use of a bulky diamine (2,2-dimethyl-1,3-propanediamine) and the resulting steric hindrance at the cyclization stage.</p>
        <p>Recently, our group explored the feasibility of synthesis of new bis-THTT using more complex polyamines as linkage other than the initially reported diamines [<xref ref-type="bibr" rid="R22">22</xref>]. The N4-benzyl polyamine <bold>14</bold> was previously synthesized according to a methodology reported by O'Sullivan <italic>et al</italic>. [<xref ref-type="bibr" rid="R23">23</xref>] via a protection-deprotection strategy using ethyl trifluoroacetate as the selective protective group for primary amines in the presence of secondary amines. The synthetic route leading to derivatives of serie X<bold>II</bold> from the benzylated spermidine was similar to the one described above (Scheme <bold><xref ref-type="fig" rid="S4">4</xref></bold>).</p>
        <p>The spermidyl linked bis-THTT series (<bold>XII</bold>) were obtained as solids in moderate yields.</p>
        <p>The experimental procedure used to obtain the THTT derivatives (mono and bis-THTT) is simple, allowing a wealth of molecular diversity depending on the nature of groups attached to both nitrogens (N-3 and N-5) of the heterocycle. </p>
      </sec>
      <sec>
        <label>2.3</label>
        <title>Proposed Reaction Mechanism for the Generation of the Thiadiazine Ring</title>
        <p>According to the authors, the formation of the thiadiazinane ring is performed via a one pot domino reaction between the pre-formed DTC, formaldehyde and the amino acid component. Despite being considered a multi-component reaction, the reactants are added in a stepwise fashion. Undoubtedly, one of the least explored aspects regarding the synthesis of THTT has been the study of the reaction pathway from the corresponding DTC. In one approach (Scheme <bold><xref ref-type="fig" rid="S5">5a</xref></bold>) the preformed DTC <bold>4</bold> is allowed to react simultaneously with formaldehyde and the corresponding amine to produce [substituted(aminomethyl)methanethionyl methylidenazanium <bold>12</bold> [<xref ref-type="bibr" rid="R20">20</xref>]. This species possesses two different reactive centers in the same molecular backbone, a protonated imine and a thiosulfanylmethylamino group. The intramolecular addition of the secondary amino group to the carbon atom of the methylidene moiety leads to the THTT ring. The formation of the THTT ring via a {[hydroxymethyl (substituted) carbamothioyl] sulfanyl}methanol intermediate 13 [<xref ref-type="bibr" rid="R13">13</xref>] was proposed (Scheme <bold><xref ref-type="fig" rid="S5">5b</xref></bold>). This process involves in situ generation of <bold>13</bold> from the corresponding DTC <bold>4</bold> and formaldehyde (<bold>5</bold>) followed by condensation with a primary amine. The isolation and characterization of an analogue of <bold>13</bold>, via a crystallization process induced by the presence of KOH, was reported [<xref ref-type="bibr" rid="R13">13</xref>].</p>
        <p>Recently, we have reported a preliminary DFT study aimed at predicting the probable cyclization mechanism of the thiadiazinane-2-thione from an intermediate of type <bold>13 </bold>[<xref ref-type="bibr" rid="R24">24</xref>]. Based on experimental facts and DFT studies, a probable cyclization route to the THTT ring from the corresponding {[hydroxymethyl(substituted) carbamothioyl] sulfanyl}methanol intermediate <bold>13</bold> in aqueous medium is proposed. Notably, water not only contributes to the reaction as a mere solvent, but also plays an active role in the reaction mechanism. As far as we know, this is the first computational study on the formation of the thiadiazinane-2-thione ring.</p>
      </sec>
    </sec>
    <sec>
      <label>3</label>
      <title>STRUCTURAL CHARACTERIZATION OF MONO AND BIS-THTT DERIVATIVES</title>
      <p>Structures of all the compounds were established on     the basis of spectroscopic data and microanalysis. IR spectroscopy of the compounds showed absorption bands ranging from 3060 to 3450 cm<sup>&#x2212;1</sup> for (OH and NH), 1690 to 1720cm<sup>&#x2212;1</sup> for (C=O) and from 1445 to 1508 cm<sup>&#x2212;1</sup> for (C=S). Although, numerous studies have been published on the synthesis and characterization of these compounds [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R14">14</xref>], it was only in 2001 we published the first exhaustive structural characterization of mono-THTT derivatives [<xref ref-type="bibr" rid="R15">15</xref>-<xref ref-type="bibr" rid="R17">17</xref>]. These studies were considered an important structural data base to facilitate the characterization of novel compounds with the THTT ring in its structure.</p>
      <p>The Nuclear Magnetic Resonance study deals with the complete <sup>1</sup>H and <sup>13</sup>C NMR assignments of a series of differently substituted THTT endowed with different organic addends on both heterocyclic nitrogen atoms (Fig. <bold><xref ref-type="fig" rid="F4">4</xref></bold>). The <sup>1</sup>H NMR spectra at 300 MHz of THTT derivatives show, in general, two singlets corresponding to ring protons H-4 and H-6 around &#x3B4; 4.50 and 4.40 respectively, besides other usual signals of the substituents. In order to assign unequivocally all NMR signals, 1D and 2D techniques such as DEPT (135), HMQC and HMBC were used [<xref ref-type="bibr" rid="R15">15</xref>].</p>
      <p>A structural study of 5-carboxy-ethyl-3-(2&#xB4;-furfurylmethyl) tetrahydro-2<italic>H</italic>-1,3,5-thiadiazine-2-thione was made by means of X-ray crystallographic analysis determining the most stable conformation in the solid state. The theoretical calculations allowed to gain a better picture of the conformational profile of the given compound by means of the semiempirical AM1 method, as well as by ab-initio calculations at Hartree-Fock level using 3.21G* and 6-31G* basis sets. <sup>1</sup>H Noe experiments had also been carried out in order to obtain information about the conformational profile of this compound in solution [<xref ref-type="bibr" rid="R16">16</xref>]. </p>
      <p>The electrospray ionisation (ESI) in negative mode of the pharmacologically significant mono-THTT derivatives, and their subsequent fragmentations using an ion-trap mass spectrometer were investigated. Experiments on sequential product ion fragmentations (MS<sup>n</sup>) were performed in order to elucidate the degradation pathways for these compounds. The data reported show that the fragmentation of the even-electron M-H<sup>-</sup> ions could proceed through an internal nucleophilic substitution displacement. Decarboxylation and extrusion of carbon disulfide are other fragmentations observed [<xref ref-type="bibr" rid="R17">17</xref>].</p>
      <p>On the other hand, the spectroscopic information gathered from previously synthesized mono-THTT derivatives [<xref ref-type="bibr" rid="R15">15</xref>-<xref ref-type="bibr" rid="R17">17</xref>] allowed to confirm the structure of the bis-THTT compounds. The structures of all the bis-THTT derivatives reported in the bibliography were established on the basis of spectroscopic data [<xref ref-type="bibr" rid="R19">19</xref>-<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R24"> 24</xref>,<xref ref-type="bibr" rid="R25"> 25</xref>]. In general the <sup>1</sup>H and <sup>13</sup>C NMR signals of each THTT-ring were undistinguishable and all series, show a similar trend in the chemical shift of the common part of the molecular backbone. The <sup>1</sup>H and <sup>13</sup>C NMR spectroscopic data of alkyl, and polyamine-linked bis(2-thioxo-[<xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R5">5</xref>]thiadiazinan-3-yl) carboxylic acids, prepared from alkyl diamines and <italic>N</italic>4-(benzyl) spermidine, were fully assigned by the combination of one- and two-dimensional experiments (DEPT, HMBC, HMQC, COSY) [<xref ref-type="bibr" rid="R25">25</xref>]. In some cases, the <sup>13</sup>C NMR experiments could not be performed because the bis-THTT derivatives were poorly soluble in DMSO at the concentration required for NMR spectroscopy [<xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20"> 20</xref>].</p>
    </sec>
    <sec>
      <label>4</label>
      <title>BIOLOGICAL ACTIVITY OF THTT DERIVATIVES</title>
      <p>The promising results of antiprotozoal activity achieved by reported THTT derivatives could be attributed to the interaction of cysteine proteinases, present in most groups of parasitic protozoa [<xref ref-type="bibr" rid="R26">26</xref>], with isothiocyanates [<xref ref-type="bibr" rid="R27">27</xref>] generated by hydrolysis of the THTT ring in a protic medium [<xref ref-type="bibr" rid="R28">28</xref>]. Notwithstanding it should not be excluded the possible interaction of the released aminoacids or dipeptides, attached to position 5 of the THTT ring, with other molecular targets, enhancing the antiparasitic activity observed of these derivatives.</p>
      <p>On the other hand, the high lipid solubility and ease of enzymatic hydrolysis [<xref ref-type="bibr" rid="R29">29</xref>] generally associated with this heterocycle, has motivated its use as a biolabile prodrug in the design of drug-delivery systems (DDS). The aforementioned properties and the possibility to attach several structurally distinct substituents to the heterocycle ring to modify either the biological or physico-chemical properties of these compounds, have prompted us to use the THTT ring as a template in many research programs aimed at the development of new antiparasitic compounds [<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R11"> 11</xref>-<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R18"> 18</xref>-<xref ref-type="bibr" rid="R22">22</xref>].</p>
      <sec>
        <label>4.1</label>
        <title>Biological Activity of Mono-THTT Derivatives</title>
        <p>In 1999, we reported for the first time the antiprotozoan properties of 34 mono-THTT derivatives (Fig. <bold><xref ref-type="fig" rid="F6">6</xref></bold>) corresponding to the series <bold>I</bold>, <bold>II</bold> and <bold>III</bold> against <italic>Trichomonas vaginalis</italic> and <italic>Trypanosoma cruzi</italic> [<xref ref-type="bibr" rid="R9">9</xref>]. One year later, we published the study on the decomposition products of their mono-THTT and their anticancer properties (Fig. <bold><xref ref-type="fig" rid="F5">5</xref></bold>) [<xref ref-type="bibr" rid="R10">10</xref>]. </p>
        <p>All mono-THTT derivatives studied showed significant <italic>in vitro</italic> antiprotozoan activity (both anti-trichomonas and anti-trypanosoma) at the highest dose tested (100 &#xB5;g/mL), except for compound <bold>L-IIIe</bold>. (Fig. <bold><xref ref-type="fig" rid="F6">6</xref></bold>). The results obtained at 10 and 1&#xB5;g/mL (Fig. <bold><xref ref-type="fig" rid="F7">7</xref></bold>) showed that the nature of substituents not afforded important differences in the trichomocidal activity (%R) of the three series studied, since most of the compounds lose their trichomonacidal activity at 10 &#xB5;g/mL. This fact seems to indicate that the lipophilic character of R<sub>1</sub> does not influence the <italic>in vitro</italic> trichomonacidal activity significantly. Only two compounds of series III (<bold>D-IIIj</bold> and <bold>IIIm)</bold> maintain their efficacy at 10 &#xB5;g/mL and again <bold>IIIm</bold> was the most active compound at 1 &#xB5;g/mL (%R=59), with a trichomonacydal effect similar to that of Metronidazole at 0.1 &#xB5;g/mL (%R=52). None of the compounds studied were more active than Metronidazole (Fig. <bold><xref ref-type="fig" rid="F6">6</xref></bold>). The most active compounds, <bold>L-IIId</bold>, <bold>D-IIIj</bold> and <bold>IIIm</bold>, that were assayed <italic>in vivo, </italic>showed a reduction in the pathogenecity index, and this was mainly true for compound <bold>IIIm </bold>[<xref ref-type="bibr" rid="R9">9</xref>].</p>
        <p>Compounds of series <bold>II</bold> and <bold>III</bold> showed trypanosomicidal activity, both at 100 and 10 &#xB5;g/mL, whilst compound of series <bold>I</bold> only showed cytostatic activity at 10 &#xB5;g/mL. This fact indicated that the lipophilic substituents at the N-3 were better than hydrophilic ones for obtaining active compounds against <italic>T. cruzi</italic>. Compounds <bold>IIc</bold>, <bold>L-IId</bold>, <bold>DL-IId</bold>, <bold>DL-IIf</bold>, <bold>IIIm</bold> and <bold>L-IIIn</bold> maintained trypanosomicidal activity at 1 &#xB5;g/mL showing a higher activity than Nifurtimox. We have found more compounds with trypanosomicidal than trichomonacidal activity (Fig. <bold><xref ref-type="fig" rid="F6">6</xref></bold>) [<xref ref-type="bibr" rid="R9">9</xref>].</p>
        <p>Taking into account the highest citotoxic activities showed by some compounds of the series <bold>I</bold>, <bold>II</bold> and <bold>III</bold> in a previous work [<xref ref-type="bibr" rid="R9">9</xref>], we studied the anticancer properties of mono-THTT derivatives (Fig. <bold><xref ref-type="fig" rid="F5">5</xref></bold>). This study has been carried out by using cytotoxicity assays against HeLa, HT-29 and Hep G2 cells. The decomposition products of thiadiazinthione <bold>IIIm</bold> have been studied and their anticancer properties evaluated (Fig. <bold><xref ref-type="fig" rid="F7">7</xref></bold>) [<xref ref-type="bibr" rid="R10">10</xref>].</p>
        <p>The results of this study could lead to the conclusion that most of the mono-THTT derivatives showed noticeable cytotoxic properties against HeLa and HT-29 but did not do so against Hep G2 cells. The compounds of series <bold>I</bold> and <bold>II</bold> were, in general, less cytotoxic than those of serie <bold>III</bold>, none of them showed a IC<sub>50</sub> lower than 10 &#xEC;mol against any cell line. Compound <bold>IIIo</bold>, detected in the decomposition of compound <bold>IIIm</bold> and presumingly in one of the other thiadiazinones, were less cytotoxic than <bold>IIIm</bold>. The nature of R<sub>1</sub> modulates the cytotoxicity of these compounds. Compounds bearing the aromatic furfuryl moiety (Series <bold>III</bold>) yielded the most interesting thiadiazinones. However, the nature of R<sub>2</sub> influences the cytotoxic activity to a lesser grade. The (S) enantiomer showed more cytotoxic properties than its (R) isomer. Derivative (S) IIIj, bearing furfuryl and L-asparagine moieties, yielded the most interesting compound which is a candidate for a future anticancer study [<xref ref-type="bibr" rid="R10">10</xref>]. These results allowed the study through QSAR methodology of mono-THTT derivatives using the novel hybrid index pMR&#x3C7; [<xref ref-type="bibr" rid="R30">30</xref>].</p>
        <p>With the aim to increase the antiprotozoan activity spectra, our group reported new biological assays to study the non-specific toxicity and anti-amastigote activity of 18 of these compounds [<xref ref-type="bibr" rid="R31">31</xref>]. Cytotoxicity assays of 24 mono-THTT were performed. The 17 compounds with higher anti-epimastigote activity and lower cytotoxicity were, therafter, screened against amastigote of <italic>Trypanosoma cruzi</italic>. Out of these 17 derivatives, <bold>(S)-IId</bold> was selected to be assayed <italic>in vivo</italic>, because of its remarkable trypanocidal properties. Nifurtimox and benzidazole were used as reference drugs. All of the compounds were highly toxic at 100 &#xB5;g/mL for macrophages and a few of them maintained this cytotoxicity even at 10 &#xB5;g/mL. Of the derivatives assayed against amastigotes, <bold>Ik</bold> and <bold>(S)-IId</bold> showed an interesting activity, which was held even at 1 &#xB5;g/mL. It is demonstrated that the high anti-epimastigote activity previously reported is mainly due to the non-specific toxicity of these compounds. <italic>In vivo</italic> assays assessed a reduction of parasitemia after the administration of <bold>(S)-IId</bold> to infected mice [<xref ref-type="bibr" rid="R31">31</xref>].</p>
        <p>In 2004 and 2005 ten mono-THTT derivatives (Fig. <bold><xref ref-type="fig" rid="F8">8</xref></bold>) were tested <italic>in vitro</italic> for antiparasitic effects against both extracellular promastigotes and intracellular amastigotes of <italic>Leishmania amazonensis </italic>[<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R33">33</xref>]<italic>. </italic>The compounds were found to be active against the amastigote form of the parasite, inhibiting parasite growing, from 10 to 89%, at a concentration of 100 &#xB5;g/mL. This activity suggests that thiadiazine derivatives could be considered as potential antileishmanial compounds (Fig. <bold><xref ref-type="fig" rid="F9">9</xref></bold>) [<xref ref-type="bibr" rid="R32">32</xref>]. </p>
        <p>These results confirmed that the THTT represent a group of compounds with significant <italic>in vitro</italic> activity against <italic>L. amazonensis </italic>and suggested that some of them could be considered for further study as new therapeuthic alternatives [<xref ref-type="bibr" rid="R32">32</xref>,<xref ref-type="bibr" rid="R33">33</xref>]. </p>
        <p>All evaluated compounds caused an irreversible inhibition of the promastigote growth either after 1h of treatment with 10 &#xB5;g/mL or after 24 h with 1 &#xB5;g/mL (Fig. <bold><xref ref-type="fig" rid="F10">10</xref></bold>). However, the compounds exhibited high toxicity and produced inhibition of the phagocytosis in the murine host cell [<xref ref-type="bibr" rid="R33">33</xref>]. The mono&#x2013;THTT tested exhibited a strong activity against <italic>L. amazonensis</italic> at low concentrations. </p>
      </sec>
      <sec>
        <label>4.2</label>
        <title>Biological Activity of Bis-THTT Derivatives</title>
        <p>It has been reported that bis-thiadiazines have antifungical, antimicrobial and antiprotozoal activity [<xref ref-type="bibr" rid="R19">19</xref>-<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R34"> 34</xref>]. Specifically with antiprotozoal activities three series of bis-THTT had been reported [<xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22"> 22</xref>,<xref ref-type="bibr" rid="R34"> 34</xref>]. The <italic>in vitro</italic> activity of compounds belonging to series <bold>VIII</bold> and <bold>IXI</bold> (Fig. <bold><xref ref-type="fig" rid="F11">11</xref></bold>) against <italic>Leishmania donovani</italic>, <italic>Trypanosoma brucei rhodesiense</italic>, and <italic>Plasmodium falciparum</italic> was studied. From these results it may be observed (Fig. <bold><xref ref-type="fig" rid="F12">12</xref></bold>) that the best activity profiles were found against <italic>T. b. rhodesiense</italic>. It is intereresting that the activity against <italic>T. b. rhodesiense</italic> seems to be favoured for compounds having linear aminoacidic residues as substituents in N-5 of the THTT ring. Despite exerting a notable activity against <italic>T. b. rhodesiense</italic>, derivatives from series <bold>VIII</bold> appeared to be more citotoxic than the analogs of series <bold>IX</bold> (Fig. <bold><xref ref-type="fig" rid="F13">13</xref></bold>) [<xref ref-type="bibr" rid="R34">34</xref>].</p>
        <p>The <italic>in-vitro</italic> activity against <italic>L. donovani, T. cruzi, T. b. rhodesiense ,</italic> and <italic>P. falciparum</italic> of some compounds of series <bold>XII</bold>, was compared with these activities for compounds of series <bold>VIII</bold> (Fig. <xref ref-type="fig" rid="F14">14</xref> and Fig. <xref ref-type="fig" rid="F15">15</xref>) [<xref ref-type="bibr" rid="R22">22</xref>]. For comparative purposes, structures <bold>VIII</bold> and <bold>XII</bold> were changed only in the nature of their connective backbone. In the bis-THTT derivatives in both series that had the same aminoacid residue (R<sub>2</sub>), the displayed protozoocidal profile against the three parasitic lines assayed was almost the same. However,          higher values of therapeutic indexes were found for compounds <bold>VIIIa&#x2013;c</bold>. Considering that both series exerted a similar protozoal activity it is possible to assume that structures <bold>XII</bold> are more cytotoxic than their alkyl tethers analogs [<xref ref-type="bibr" rid="R22">22</xref>].</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <label>5</label>
      <title>CONCLUSIONS</title>
      <p>The most extensive method reported to obtain THTT derivatives proceed via a dithiocarbamate salt intermediary. This experimental procedure is simple and allows a wealth of molecular diversity depending on the nature of groups attached to both nitrogens of the heterocycle. </p>
      <p>All THTT synthesized showed biological activity against some trypanosomatids at doses of 100 &#xB5;g/mL, at low doses some of them showed important activities. The results presented in this review made it possible to analyze how the chemical nature of N-3 and/or N-5-substituents in the THTT ring influences the overall activity/cytotoxicity profile against some protozoa parasites. The introduction of two THTT rings in the same molecule potentiated the antiprotozoan activity of these derivatives. </p>
      <p>The excellent properties of the THTT scaffold made its use as the main core in many projects for the development of new antiparasitic agents and the synthesis of novel bis-THTT derivatives employing other polyamines as bridging moieties will be also the theme of future investigations.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sachs</surname>
              <given-names>J D</given-names>
            </name>
            <name>
              <surname>Hotez</surname>
              <given-names>P J</given-names>
            </name>
          </person-group>
          <article-title>Fighting tropical diseases</article-title>
          <source>Science</source>
          <year>2006</year>
          <volume>311</volume>
          <fpage>1521</fpage>
          <pub-id pub-id-type="pmid">16543418</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Renslo</surname>
              <given-names>A R</given-names>
            </name>
            <name>
              <surname>McKerrow</surname>
              <given-names>J H</given-names>
            </name>
          </person-group>
          <article-title>Drug discovery and development for neglected parasitic diseases</article-title>
          <source>Nat.Chem. Biol</source>
          <year>2006</year>
          <volume>2</volume>
          <fpage>701</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">17108988</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nwaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hudson</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Innovative lead discovery strategies for tropical diseases</article-title>
          <source>Nat. Rev. Drug Discov</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>941</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">17080030</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redtenbacher</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liebig</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ueber das carbothildin</article-title>
          <source>Liebigs Ann. Chem</source>
          <year>1848</year>
          <volume>65</volume>
          <fpage>43</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ainley</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The constitution of the so-called carbothialdines and the preparation of some homologous compounds</article-title>
          <source>J. Chem. Soc</source>
          <year>1944</year>
          <volume>00</volume>
          <fpage>147</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rieche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hilgetg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Martini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nejedh</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Schlege</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>New compounds with bactericidal and fungicidal activity and which inhibit the growth of viruses. I. 2-thiotetrahydro-1,3,5-thiadiazine ("carbothialdine") and dithiocarbamic acid salts</article-title>
          <source>Arch. Pharm</source>
          <year>1960</year>
          <volume>293</volume>
          <fpage>957</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">13741504</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zsolnai</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial effects of thiocyanates, isothiocyanates and potential isothiocyanate forming substances</article-title>
          <source>Arzneim-Forsch. Drug Res</source>
          <year>1971</year>
          <volume>21</volume>
          <fpage>121</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">4929243</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weaffen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schade</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Relation between chemical structure and antimicrobial action. 1. Studies on the bacteriostatic properties of some 2-thiotetrahydro-1,3,5 thiadiazines</article-title>
          <source>Pharmazie</source>
          <year>1963</year>
          <volume>18</volume>
          <fpage>420</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">14061160</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ochoa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>G&#xF3;mez Barrio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muelas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nogal</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>R A</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Antiprotozoan properties of new 3,5-Disubstituted-Tetrahydro- 2H-1,3,5-Thiadiazin-2-Thione derivatives</article-title>
          <source>Arzneimitttel Forschung-Drug Res</source>
          <year>1999</year>
          <volume>49</volume>
          <issue>II</issue>
          <fpage>764</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10514905</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Study on the decomposition products thiadiazinthione and their anti-cancer properties</article-title>
          <source>Arzneimittel Forschung Drug Res</source>
          <year>2000</year>
          <volume>50</volume>
          <issue>II</issue>
          <fpage>854</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">11050705</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katiyar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tiwari</surname>
              <given-names>V K</given-names>
            </name>
            <name>
              <surname>Tripathi</surname>
              <given-names>R P</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chaturvedi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>B S</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antimycobacterial activity of 3,5-disubstituted thiadiazine thiones</article-title>
          <source>Bioorg. Med. Chem</source>
          <year>2003</year>
          <volume>11</volume>
          <issue>20</issue>
          <fpage>4369</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">13129574</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Shorbagi</surname>
              <given-names>A-N</given-names>
            </name>
          </person-group>
          <article-title>New tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives as potential ntimicrobial agents</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem</source>
          <year>2000</year>
          <volume>333</volume>
          <fpage>281</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboul-Fadl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hussein</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>El-Shorbagi</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Khallil</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>New 2H tetrahydro-1,3,5- thiadiazine-2-thiones incorporating glycine and glycinamide as potential antifungal agents</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem</source>
          <year>2002</year>
          <volume>335</volume>
          <fpage>438</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboul-Fadl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Khallil</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, degradation kinetics and <italic>in vitro</italic> antimicrobial activity of tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives of some beta-amino acids</article-title>
          <source>Arzneim- Forsch. Drug Res</source>
          <year>2003</year>
          <volume>53</volume>
          <fpage>526</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">12918220</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Molero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Seoane</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>1H and 13C Spectra assignment of 3,5-disubstituted tetrahydro-2H-1,3,5-disubstituted tetrahydro-2H-1,3,5-. Thiadiazin-2-thione derivatives</article-title>
          <source>Magn. Reson. Chem</source>
          <year>2001</year>
          <volume>39</volume>
          <fpage>22</fpage>
          <lpage>224</lpage>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Seoane</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Novoa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Blaton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Peeters</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>De Ranter</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A joint theoretical and experimental structural study of N, N-disubstituted tetrahydro-2H-1,3,5- thiadiazines</article-title>
          <source>Tetrahedron</source>
          <year>2001</year>
          <volume>57</volume>
          <fpage>9543</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Seoane</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Suarez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kayali</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Study of the electrospray ionization and ion trapp fragmentation of negative ions of new 3,5-disubstituted tretahydro-(2H)-1,3,5-thiadizine-2-thione</article-title>
          <source>Rapid Commun. Mass Spectrom</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>758</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">11344534</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozcelik</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Ersan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ural</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Ozkan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ertan</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of 3-substituted-5-(4- carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives as antifibrinolytic and antimicrobial agents</article-title>
          <source>Arzneimittel Forschung</source>
          <year>2007</year>
          <volume>57</volume>
          <issue>8</issue>
          <fpage>554</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17915644</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hussein</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>El-Shorbagi</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Khallil</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antifungal activity of 3,3&#xB4;-ethylenebis (5-alkyl-1,3,5-thiadiazine-2-thiones)</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem</source>
          <year>2001</year>
          <volume>334</volume>
          <fpage>305</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El Bialy</surname>
              <given-names>SAA</given-names>
            </name>
            <name>
              <surname>Abdelal</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>El-Shorbagi</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Kheira</surname>
              <given-names>SMM</given-names>
            </name>
          </person-group>
          <article-title>2,3-Bis(5-alkyl-2-thiono-1,3,5- thiadiazin-3-yl) propionic acid: One-pot Domino synthesis and antimicrobial activity</article-title>
          <source>Arch. Pharm. Chem. Live Sci</source>
          <year>2005</year>
          <volume>338</volume>
          <fpage>38</fpage>
          <lpage>43</lpage>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vega</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rolon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Montero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nogal</surname>
              <given-names>J.J</given-names>
            </name>
            <name>
              <surname>G&#xF3;mez- Barrio</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antiprotozoan evaluation of new alkyl-linked bis(2-thioxo-[1,3,5]thiadiazinan-3- yl) carboxylic acids</article-title>
          <source>Bioorg. Med. Chem</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>3413</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">15848753</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yardley</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Suarez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Perez-Pineiro</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Antiprotozoal evaluation of New N4-(benzyl)Spermidyl-linked bis(1,3,5-thiadiazinane-2-thione)</article-title>
          <source>Archiv der Pharmacie</source>
          <year>2008</year>
          <volume>341</volume>
          <fpage>318</fpage>
          <lpage>29</lpage>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#xB4;Sullivan</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Durham</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Rattendi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bacchi</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Polyamine derivatives as inhibitors of Trypanothione reductase and assessment of their tripanocidal activities</article-title>
          <source>Bioorg. Med. Chem</source>
          <year>1997</year>
          <volume>5</volume>
          <fpage>2145</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">9459012</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>&#xC1;lvarez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Montero</surname>
              <given-names>A L</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Perez-Pineiro</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A computational approach to the synthesis of 1,3,5-thiadiazinane-2 thiones in aqueous medium: theoretical evidence for water-promoted heterocyclization</article-title>
          <source>J. Mol. Model</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>641</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">18488255</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molero</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Coro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Herrera</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>1H and 13C NMR spectral Assignment of Alkyl and Polyamine-linked Bis (2-thioxo-[1,3,5]thiadiazinan-3-yl) carboxylic acids</article-title>
          <source>Magn. Reson. Chem</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>93</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">17103485</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>North</surname>
              <given-names>M J</given-names>
            </name>
            <name>
              <surname>Mottran</surname>
              <given-names>J C</given-names>
            </name>
            <name>
              <surname>Coombs</surname>
              <given-names>G HM J</given-names>
            </name>
          </person-group>
          <article-title>Cysteine proteinases of parasitic protozoa</article-title>
          <source>Parasitol. Today</source>
          <year>1990</year>
          <volume>6</volume>
          <fpage>270</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">15463360</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goksoyr</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Chemical and fungicidal reactions of 3,5-dimethyltetrahydro-l,3,5-thiadiazine-2-thione</article-title>
          <source>Acta Chem. Scand</source>
          <year>1964</year>
          <volume>18</volume>
          <fpage>1341</fpage>
          <lpage>52</lpage>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aboul-Fadl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>El-Shorbagi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>New prodrug approach for amino acids and amino-acid-like drugs</article-title>
          <source>Eur. J. Med. Chem</source>
          <year>1996</year>
          <volume>31</volume>
          <fpage>165</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Shorbagi</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Model for delivery of amines through incorporation into a tetrahydro-2H-1,3,5- thiadiazine-2-thione structure</article-title>
          <source>Eur. J. Med. Chem</source>
          <year>1994</year>
          <volume>29</volume>
          <fpage>11</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carrasco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Padr&#xF3;n</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Quantitative structure antitumoral-activity relationships of thiadiazinthione derivatives using the novel hybrid molecular index</article-title>
          <source>J. Pharm. Pharm. Sci</source>
          <year>2005</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>586</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">16401405</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muelas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Escario</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>G&#xF3;mez-Barrio</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>In Vitro and <italic>in vivo</italic> assays of 3,5,-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives against Trypanosoma cruzi</article-title>
          <source>Mem. Inst. Oswaldo Cruz Rio de Janeiro</source>
          <year>2002</year>
          <volume>97</volume>
          <fpage>269</fpage>
          <lpage>72</lpage>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monzote</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Montalvo</surname>
              <given-names>A M</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Effect of thiadiazine derivatives on intracellular amastigotes of <italic>Leishmania amazonensis</italic></article-title>
          <source>Mem. Inst. Oswaldo Cruz Rio de Janeiro</source>
          <year>2004</year>
          <volume>99</volume>
          <issue>3</issue>
          <fpage>329</fpage>
          <lpage>30</lpage>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monzote</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Montalvo</surname>
              <given-names>A M</given-names>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title><italic>In vitro</italic> activities of thiadiazine derivatives against Leishmania amazonensis</article-title>
          <source>Arzneim-Forst. Drug Res</source>
          <year>2005</year>
          <volume>55</volume>
          <issue>4</issue>
          <fpage>232</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">15901047</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Atherton</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wharton</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yardeley</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Alva-rez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Alkyl-linked bis-THTT derivatives as potent <italic>in vitro</italic> trypanocidal agents</article-title>
          <source>Bioorg. Med. Chem. Lett</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>1312</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">16343898</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figures and Schemes</title>
      <fig id="F1" position="float">
        <label>Fig. (1)</label>
        <caption>
          <p>3,5-disubstituted tetrahydro-2<italic>H</italic>-1,3,5-thiadiazine-2-thione scaffold (mono-THTT) and alkyl-linked bis-(2-thioxo-[1,3,5] thiadiazinan-3-yl) carboxylic acids (bis-THTT).</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Fig. (2)</label>
        <caption>
          <p>Representative mono-THTT synthesized.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Fig. (3)</label>
        <caption>
          <p>General structures of bis-THTT synthesized.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F3"/>
      </fig>
      <fig id="F4" position="float">
        <label>Fig. (4)</label>
        <caption>
          <p>Compounds studies by NMR 1D and 2D techniques.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F4"/>
      </fig>
      <fig id="F5" position="float">
        <label>Fig. (5)</label>
        <caption>
          <p>General structure of mono-THTT derivatives (Series <bold>I</bold>, <bold>II</bold> and <bold>III</bold>) assays like antiprotozoan drugs against Trichomonas vaginalis and Trypanosoma cruzi; and like anticancer drugs against HeLa, HT-29 and Hep G2 cells.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F5"/>
      </fig>
      <fig id="F6" position="float">
        <label>Fig. (6)</label>
        <caption>
          <p>Percentages of reduction (positive) and/or growth (negative) at concentrations of 10 and 1&#x3BC;g/mL assayed <italic>in vitro</italic> against T. vaginalis and T. cruzi.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F6"/>
      </fig>
      <fig id="F7" position="float">
        <label>Fig. (7)</label>
        <caption>
          <p>Cytotoxicity (IC<sub>50</sub> (&#xB5;mol/l)) of compounds belonging to series <bold>I</bold>, <bold>II</bold> and <bold>III</bold> against HeLa, HT-29 and Hep G2 cells.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F7"/>
      </fig>
      <fig id="F8" position="float">
        <label>Fig. (8)</label>
        <caption>
          <p>General structure of the mono-THTT (Series <bold>III</bold>) tested <italic>in vitro</italic> for antiparasitic effects against both extracellular promastigotes and intracellular amastigotes of <italic>Leishmania amazonensis</italic>.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F8"/>
      </fig>
      <fig id="F9" position="float">
        <label>Fig. (9)</label>
        <caption>
          <p>Effect of mono-THTT derivatives and Glucantine (Glu) on intracellular amastigote.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F9"/>
      </fig>
      <fig id="F10" position="float">
        <label>Fig. (10)</label>
        <caption>
          <p>Effects of mono-THTT derivatives <bold>III</bold> on the L. amazonensis growth inhibition. A. Promastigotes were incubated in the presence of 10 &#xB5;g/mL; after 1h of treatment (blue column); incubated 5 days in fresh medium (violet columns). B</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F10"/>
      </fig>
      <fig id="F11" position="float">
        <label>Fig. (11)</label>
        <caption>
          <p>General structures of bis-THTT derivatives tested against <italic>Leishmania donovani, Trypanosoma brucei rhodesiense,</italic> and <italic>Plasmodium falciparum</italic>.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F11"/>
      </fig>
      <fig id="F12" position="float">
        <label>Fig. (12)</label>
        <caption>
          <p><italic>In vitro</italic> activity of compounds belonging to series <bold>VIII</bold> and <bold>IX</bold> against <italic>Leishmania donovani, Trypanosoma brucei rhodesiense</italic>, and <italic>Plasmodium falciparum</italic>.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F12"/>
      </fig>
      <fig id="F13" position="float">
        <label>Fig. (13)</label>
        <caption>
          <p>Cytotoxicity of bis-THTT of series <bold>VIII</bold> and <bold>IX</bold>.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F13"/>
      </fig>
      <fig id="F14" position="float">
        <label>Fig. (14)</label>
        <caption>
          <p>Bis-THTT structures (<bold>VIII</bold> and <bold>XII</bold>).</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F14"/>
      </fig>
      <fig id="F15" position="float">
        <label>Fig. (15)</label>
        <caption>
          <p>Results for <italic>in-vitro</italic> anti-protozoal activity of N4-(benzyl)spermidinyl-linked bis-THTT and their hexyl-linked bis-THTT analogs.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_F15"/>
      </fig>
      <fig id="S1" position="float">
        <label>Scheme 1</label>
        <caption>
          <p>General procedure for obtaining mono THTT.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_S1"/>
      </fig>
      <fig id="S2" position="float">
        <label>Scheme 2</label>
        <caption>
          <p>Solid Phase Synthesis of mono-THTT derivatives (<bold>I</bold>).</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_S2"/>
      </fig>
      <fig id="S3" position="float">
        <label>Scheme 3</label>
        <caption>
          <p>General procedure for obtaining bis-THTT synthesized.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_S3"/>
      </fig>
      <fig id="S4" position="float">
        <label>Scheme 4</label>
        <caption>
          <p>Synthetic route leading to bis-THTT (<bold>XII</bold>) from the benzylated spermidine.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_S4"/>
      </fig>
      <fig id="S5" position="float">
        <label>Scheme 5</label>
        <caption>
          <p>Proposed reaction mechanism for the generation of the THTT ring.</p>
        </caption>
        <graphic xlink:href="TOMCJ-5-51_S5"/>
      </fig>
    </sec>
  </back>
</article>
